• 01 Aug 25
 

Helios Underwriting - Total Voting Rights


Helios Underwriting PLC | HUW | 208 0 0.0% | Mkt Cap: 151.1m



RNS Number : 4684T
Helios Underwriting Plc
01 August 2025
 

1 August 2025                                     

 

Helios Underwriting plc

('Helios' or 'the Company')

 

Total Voting Rights

 

As at 31 July 2025, the Company's issued share capital consisted of 78,268,186 ordinary shares of £0.10 each ("Ordinary Shares"). The Company holds 5,630,255 Ordinary Shares in treasury. The total number of voting rights in the Company is therefore 72,637,931. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

Helios Underwriting plc

John Chambers - Interim Executive Chairman                                +44 (0)203 965 6441 

Adhiraj Maitra - Director of Finance and Operations

 

Deutsche Numis (Nomad and Broker)

Giles Rolls / Charles Farquhar                                                            +44 (0)20 7601 6100

 

FTI Consulting

Ed Berry                                                                                 +44 (0)7703 330 199

Nathan Hambrook-Skinner                                                 +44 (0)7977 817 092

Christian Harte                                                                     +44 (0)7974 288 763

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRWPUMWMUPAGCG